Solesence Inc(SLSN)

搜索文档
Solesence Inc(SLSN) - 2023 Q2 - Quarterly Report
2023-08-11 04:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _______ to _______ Commission File Number: 000-22333 Nanophase Technologies Corporation (Exact name of registrant as specified in its charter) (State or other jurisdi ...
Solesence Inc(SLSN) - 2023 Q1 - Quarterly Report
2023-05-13 04:12
Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _______ to _______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 1319 Marquette Drive, Romeoville, Illinois 60446 (Address of principal executive offices, and zip code) Registrant's telephone number, including a ...
Solesence Inc(SLSN) - 2022 Q4 - Annual Report
2023-03-30 04:36
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM_____ TO_____ COMMISSION FILE NUMBER 000-22333 NANOPHASE TECHNOLOGIES CORPORATION (Exact name of registrant as specified in its charter) of incorporation or organization) Dela ...